...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Term sheet and enterprise valuation

Actually there would be no legal basis for not telling everyone what is going on,we are not a publicly traded entity.If we were dealing with competitive bids etc there might be a reason to not publicly disclose but even then to say we have 2 entities that we are talking to would not violate any confidentiality.So please no the lawyers said BS.

Share
New Message
Please login to post a reply